Please find the attached file for Statement of Deviation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yogi Limited has filed a quarterly compliance statement confirming that there has been no deviation or variation in the use of funds raised through a preferential issue. The company raised a total of Rs. 38.83 crore by allotting 1.5 crore convertible warrants on 27 December 2024 (Rs. 12 crore received), followed by conversion of warrants into 1.09 crore equity shares on 27 March 2025 (Rs. 26.30 crore) and 22 lakh equity shares on 7 April 2025 (Rs. 52.8 lakh). The entire Rs. 38.83 crore has been fully utilised towards the originally stated objectives of improving market share, meeting working capital needs, and strengthening the company's financial position. The Audit Committee and auditors have raised no objections, confirming funds were used as intended.
This is a routine, positive compliance disclosure — it reassures shareholders that the company used all the money raised exactly as promised, with no misuse. However, retail investors should note that the warrants have already been converted into equity shares, meaning share dilution has already occurred. No negative impact on stock price is expected from this filing.